Cardiac mTOR protects the heart against ischemia-reperfusion injury
about
Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.Leucine-enriched essential amino acids attenuate inflammation in rat muscle and enhance muscle repair after eccentric contractionImpairment of Excitation-Contraction Coupling in Right Ventricular Hypertrophied Muscle with Fibrosis Induced by Pulmonary Artery BandingThree-dimensional myocardial scarring along myofibers after coronary ischemia-reperfusion revealed by computerized images of histological assays.Moderate lifelong overexpression of tuberous sclerosis complex 1 (TSC1) improves health and survival in miceRapamycin extends life and health in C57BL/6 miceDeficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycinmTORC2 phosphorylation of Akt1: a possible mechanism for hydrogen sulfide-induced cardioprotection.Late-life rapamycin treatment reverses age-related heart dysfunction.Mechanistic target of rapamycin complex 2 protects the heart from ischemic damageSevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signalingbFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia/reperfusion via the activation of the PI3K/Akt/mTOR pathway.Identification of protein network alterations upon retinal ischemia-reperfusion injury by quantitative proteomics using a Rattus norvegicus modelHealth Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout LifeCardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion.Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway.N-n-butyl haloperidol iodide protects cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy.Targets, trafficking, and timing of cardiac autophagyCardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart.CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury.Danshensu alleviates cardiac ischaemia/reperfusion injury by inhibiting autophagy and apoptosis via activation of mTOR signalling.Metabolomics reveals the mechanisms for the cardiotoxicity of Pinelliae Rhizoma and the toxicity-reducing effect of processingReperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK.Mammalian target of rapamycin signaling in cardiac physiology and disease.The cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling pathway.MicroRNA-144 is a circulating effector of remote ischemic preconditioning.Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes.The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus.Role of mechanistic target of rapamycin (mTOR) in renal function and ischaemia-reperfusion induced kidney injury.Early and short-term triiodothyronine supplementation prevents adverse post-ischemic cardiac remodeling: role of transforming growth factor-β1 and anti-fibrotic miRNA signaling.Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effectsThe AMPK Agonist PT1 and mTOR Inhibitor 3HOI-BA-01 Protect Cardiomyocytes After Ischemia Through Induction of Autophagy.Overexpression of microRNA-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction.Nicotinamide Adenine Dinucleotide Protects against Spinal Cord Ischemia Reperfusion Injury-Induced Apoptosis by Blocking Autophagy.Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.Protective Effects of the Mechanistic Target of Rapamycin against Excess Iron and Ferroptosis in Cardiomyocytes.Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo.Influence of the Novel ATP-Competitive Dual mTORC1/2 Inhibitor AZD2014 on Immune Cell Populations and Heart Allograft Rejection.Hyperbaric oxygen protects against myocardial reperfusion injury via the inhibition of inflammation and the modulation of autophagy.
P2860
Q27342649-A8DE1A9D-F2E4-4B1E-871B-057DCF6E6C7CQ28386920-23DA1154-9C62-461E-9463-19B3C5A482D5Q28469354-41BF749C-42BB-429A-B746-E721E9F05935Q30589568-6977B31C-24BC-4F88-B2E3-5BC1AD0B280AQ33678212-7C7A92FC-8DD2-429A-84E2-1161F10B3DDAQ33684583-656542A5-7C27-4F62-83E8-DD0E2B8124BAQ33719493-58F87521-2C26-4D33-BAE7-C069C0EAB605Q33783826-8A01F9C8-B49C-4F3B-99B9-FDE5840A6981Q33903651-FB9CC54E-5A62-4899-A82B-C6174B152531Q34039918-8A56C163-5662-4EA3-969E-76D62D4C8E9AQ34628699-39065D28-F278-4624-AF21-B8B201AC46D9Q35193724-7C1EFFC8-964F-4F9E-BB76-32AF7540008FQ35535755-8289C773-880C-4A06-BAE5-DD13EE40D0E6Q35611152-214D30A2-7084-4DD5-9F6D-835136DF3EBFQ35749631-479DD7AF-9D76-4175-937D-7A7CCDA9837DQ36171264-24BB5AE0-DA2E-43E0-8463-758C5BE97B06Q36392865-19D92513-2298-4097-B020-ED52A35FD50CQ36413023-697732FA-7876-4D20-8150-FCD199E67DCFQ36413143-A7C9FDB1-7D5C-4D27-B9C5-0D4FB405C9FBQ36479676-1D7C94EF-1566-4506-9E96-906C91208C38Q37095190-5FC7AF4B-2077-4DC6-A042-A0920FB08B64Q37251596-29B8B4E4-719F-4812-ABB0-0B6FFDEAE2E2Q37307148-9B06DB39-491C-4352-9BC6-49DADE2CAD0BQ37714720-7A41ECE2-7714-49A6-BD1E-126F3E7A9E51Q37715817-20F82EE6-060E-44B7-AF08-969F10895EE6Q38243667-BE918080-C3FA-41E7-9C04-47DE15D10546Q39154143-AFD55343-CBC5-4692-A1E9-512651F71805Q39180915-E602E7B1-735A-4DB0-A11D-F77E4C1FA2F8Q39256900-ECD728A5-1547-40AA-A4D6-D71116992424Q39459761-A05C9EEC-22D9-4F3D-A30F-B14385B29A33Q39800297-8EDC0742-6EA2-4905-AD1E-ABD75DB5D2E8Q40630534-E1F830AD-B39C-4C10-B658-3F4ED46A8642Q41080218-8B5112AA-EBFB-4E5E-9F7E-A026BDA7F6F6Q42067604-C45A9876-9321-4726-95E6-21F202ADC3A2Q42315034-2D112099-5C79-451A-8DAE-4A7224CADA65Q45012762-5AF618B3-E907-4F5D-B325-FF29CF2CE84BQ46263621-F29D46EB-48CF-47BC-8650-96CAC824D051Q46307231-ED39AF23-25CD-44CF-9CB7-C433ECA5CB64Q47835201-F7CE3B81-1FCA-446E-8134-8ADF01932D24Q49452793-4FE47ACE-A0C9-4957-AEA1-349A9D6D3FBB
P2860
Cardiac mTOR protects the heart against ischemia-reperfusion injury
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cardiac mTOR protects the heart against ischemia-reperfusion injury
@ast
Cardiac mTOR protects the heart against ischemia-reperfusion injury
@en
type
label
Cardiac mTOR protects the heart against ischemia-reperfusion injury
@ast
Cardiac mTOR protects the heart against ischemia-reperfusion injury
@en
prefLabel
Cardiac mTOR protects the heart against ischemia-reperfusion injury
@ast
Cardiac mTOR protects the heart against ischemia-reperfusion injury
@en
P2093
P2860
P1476
Cardiac mTOR protects the heart against ischemia-reperfusion injury
@en
P2093
Anthony Rosenzweig
Brendan T Inouye
Chun-Yang Xiao
Marielle Scherrer-Crosbie
Masaya Takahashi
Takashi Matsui
Toshinori Aoyagi
Yoichiro Kusakari
P2860
P304
P356
10.1152/AJPHEART.00241.2012
P50
P577
2012-05-04T00:00:00Z